LCM
RXDX

Legato Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Legato Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,074
Closed -$867K – 627
2023
Q1 		$867K Sell
8,074
-1,557
-16% -$167K 0.16% 229
2022
Q4 		$1.06M Buy
+9,631
New +$1.06M 0.2% 166